Levy Wealth Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$400K Buy
1,282
+14
+1% +$4.11K 0.1% 68
2024
Q1
$365K Hold
1,268
0.1% 70
2023
Q4
$365K Buy
1,268
+7
+0.6% +$1.91K 0.1% 70
2023
Q3
$339K Buy
1,261
+7
+0.6% +$1.75K 0.11% 74
2023
Q2
$278K Buy
1,254
+11
+0.9% +$2.55K 0.08% 93
2023
Q1
$300K Buy
1,243
+251
+25% +$61.6K 0.09% 84
2022
Q4
$260K Sell
992
-26
-3% -$6.97K 0.09% 75
2022
Q3
$229K Buy
+1,018
New +$247K 0.1% 67

Other funds holding AMGN

Levy Wealth Management Group's AMGN Position: Q2 2024 in Review

Levy Wealth Management Group increased its Amgen (AMGN) stake by 1.1% in Q2 2024, buying an estimated $4.11K and bringing the position to 1,282 shares worth $400K. The position accounts for 0.1% of the portfolio, ranked #68.

Levy Wealth Management Group first reported a position in AMGN in Q3 2022 and has held it in 8 quarters since. 2,789 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Levy Wealth Management Group held 1,282 shares of Amgen worth $400K as of Q2 2024.
  • Levy Wealth Management Group bought 14 Amgen shares in Q2 2024, an estimated $4.11K.
  • Amgen made up 0.1% of Levy Wealth Management Group's portfolio in Q2 2024, its #68 holding.
  • Levy Wealth Management Group first reported a position in Amgen in Q3 2022 and has held it in 8 quarters since.
  • 2,789 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Levy Wealth Management Group's 13F filing for Q2 2024, filed 25 Jul 2024.